Biomarkers of Chinese advanced cancer patients based on real-world data: Actionable genomic alterations and tumor mutational burden.

被引：0
|
作者：
Wang, HaiTao
Wang, Huina
Guo, Rongyun
Li, Mingwei
Zhang, Yanrui
Lou, Feng
Cao, Shanbo
机构：
[1] Tianjin Med Univ, Tianjin, Peoples R China
[2] Acornmed Biotechnol Co Ltd, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14280
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14280
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Enabling Real-World Data to Accelerate the Development of Innovative Cancer Biomarkers
    Yeh, Chen
    GLOBAL MEDICAL GENETICS, 2023, 10 (02): : 97 - 100
  • [42] Diagnosis, treatment and burden in advanced ovarian cancer: a UK real-world survey of healthcare professionals and patients
    Tookman, Laura
    Green, Clare
    Leonard, Katy
    Clare, Victoria
    Patel, Nafisa
    Dunlop, Farah
    McCormack, Stephen
    Ellis, Hilary
    de Courcy, Joanna
    Bateman, Lauren
    Borley, Jane
    FUTURE ONCOLOGY, 2024, 20 (23) : 1657 - 1673
  • [43] Target-based genomic profiling of ctDNA from Chinese non-small cell lung cancer patients: a result of real-world data
    Huijuan Chen
    Aiqin Wang
    Jing Wang
    Zeming He
    Yanqiu Mao
    Liming Liu
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 1867 - 1876
  • [44] Target-based genomic profiling of ctDNA from Chinese non-small cell lung cancer patients: a result of real-world data
    Chen, Huijuan
    Wang, Aiqin
    Wang, Jing
    He, Zeming
    Mao, Yanqiu
    Liu, Liming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (07) : 1867 - 1876
  • [45] Characterization of genomic alterations, tumor mutational burden and PDL1 expression in 181 Chinese hepatocellular carcinomas.
    Ling, Qi
    Yang, Pingzhou
    Tang, Xiaofeng
    Hong, Defei
    Qu, Linlin
    Feng, Yujie
    Ou, Yimeng
    Li, Yong
    Shi, Yujun
    Xiao, Chunwen
    Li, Yanlin
    Wang, Kai
    Wang, Weifeng
    Bu, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Immune checkpoint inhibition for the treatment of metastatic breast cancer with high tumor mutational burden: Real world clinical and genomic correlates of response
    Mai, Nicholas
    Safonov, Anton
    Marra, Antonio
    Chen, Yuan
    Chandarlapaty, Sarat
    Razavi, Pedram
    Plitas, George
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Real-world outcomes for Chinese breast cancer patients with tumor location of central and nipple portion
    Fu, Wei-Da
    Wang, Xiao-Hui
    Lu, Kang-Kang
    Lu, Yi-Qiao
    Zhou, Jie-Yu
    Huang, Qi-Di
    Guo, Gui-Long
    FRONTIERS IN SURGERY, 2022, 9
  • [48] Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study
    Stenzinger, Albrecht
    Endris, Volker
    Budczies, Jan
    Merkelbach-Bruse, Sabine
    Kazdal, Daniel
    Dietmaier, Wolfgang
    Pfarr, Nicole
    Siebolts, Udo
    Hummel, Michael
    Herold, Sylvia
    Andreas, Johanna
    Zoche, Martin
    Toegel, Lars
    Rempel, Eugen
    Maas, Joerg
    Merino, Diana
    Stewart, Mark
    Zaoui, Karim
    Schlesner, Matthias
    Glimm, Hanno
    Froehling, Stefan
    Allen, Jeff
    Horst, David
    Baretton, Gustavo
    Wickenhauser, Claudia
    Tiemann, Markus
    Evert, Matthias
    Moch, Holger
    Kirchner, Thomas
    Buettner, Reinhard
    Schirmacher, Peter
    Jung, Andreas
    Haller, Florian
    Weichert, Wilko
    Dietel, Manfred
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (07) : 1177 - 1189
  • [49] The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
    Zill, Oliver A.
    Banks, Kimberly C.
    Fairclough, Stephen R.
    Mortimer, Stefanie A.
    Vowles, James V.
    Mokhtari, Reza
    Gandara, David R.
    Mack, Philip C.
    Odegaard, Justin I.
    Nagy, Rebecca J.
    Baca, Arthur M.
    Eltoukhy, Helmy
    Chudova, Darya I.
    Lanman, Richard B.
    Talasaz, AmirAli
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 3528 - 3538
  • [50] Real-World Experience With Pembrolizumab in Patients With Advanced Lung Cancer
    Peng, Tzu Rong
    Wu, Ta Wei
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (04) : E537 - E538
12345